Urokinase-type Plasminogen Activator Receptor (uPAR) Ligation Induces a Raft-localized Integrin Signaling Switch That Mediates the Hypermotile Phenotype of Fibrotic Fibroblasts [PDF]
L. Grove +12 more
openalex +1 more source
Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia [PDF]
Muhammad Said El-Mekkawy +2 more
openalex +1 more source
Fibroblast Growth Factor 23, Hepatocyte Growth Factor, Interleukin‐6, High‐Sensitivity C‐Reactive Protein and Soluble Urokinase Plasminogen Activator Receptor. Inflammation Markers in Chronic Haemodialysis Patients? [PDF]
Gabriel Almroth +6 more
openalex +1 more source
The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma. [PDF]
Zampieri C +5 more
europepmc +1 more source
Urokinase-Type Plasminogen Activator Receptor: A Beacon of Malignancy? [PDF]
Ronny Drapkin +2 more
openalex +1 more source
409. Inhibition of Urokinase Receptor (uPAR) Expression by RNA-Cleaving Catalytic DNA (DNAzyme) Containing Antisense uPAR [PDF]
openalex +1 more source
Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease.
B. Meijers +9 more
semanticscholar +1 more source
Soluble Urokinase Plasminogen Activator Receptor Levels in Tuberculosis Patients at High Risk for Multidrug Resistance [PDF]
Tri Yudani Mardining Raras +2 more
openalex +1 more source
Identification of plasminogen activator urokinase receptor-related non-coding RNA and immune prognostic signature for non-small cell lung cancer. [PDF]
Cheng Y +8 more
europepmc +1 more source

